MUNICH, GERMANY, 21. June 2019: Nanion is pleased to announce the launch of the SyncroPatch 384i. This new giga-ohm seal HTS automated patch clamp platform provides effortless ion channel screening coupled with unmatched flexibility, ease-of-use and reliability.
WuXi AppTec Research Service Division announced the acquisition of a SyncroPatch 384PE automated patch clamp system in Shanghai, China, within their Newsletter (December 10. 2018).
LIVINGSTON, N.Y. USA, 19. November 2018: Nanion is pleased to announce the recent hire of Dr. Ronald Knox as Account Executive, who brings 18+ years of experience in drug discovery, target validation and translational research in neuroscience, cardiovascular and immunotherapies.
LIVINGSTON, N.J., MUNICH, Germany, September 26, 2018: Nanion announced today that Charles River Laboratories has purchased two SyncroPatch 384PE high-throughput patch clamp instruments. This purchase reflects an investment in screening technologies and assay development, while accommodating the rising demand in contract service for globally shared clients. The instruments will be delivered to Charles River (Cleveland site; former ChanTest) in November of this year and will be used for various ion channel screening & profiling services, including cardiac safety screening, efficacy, and SAR studies.
